Bone Marrow Mesenchymal Stem Cell-Derived Extracellular Vesicle Infusion for the Treatment of Respiratory Failure From COVID-19

Saved in:

Bibliographic Details
Published in	Chest Vol. 164; no. 6; pp. 1444 - 1453
Main Authors	Lightner, Amy L., Sengupta, Vikram, Qian, Sascha, Ransom, John T., Suzuki, Sam, Park, David J., Melson, Timothy I., Williams, Brian P., Walsh, James J., Awili, Mustafa
Format	Journal Article
Language	English
Published	01.12.2023
Online Access	Get full text
ISSN	0012-3692
DOI	10.1016/j.chest.2023.06.024

Cover

Author	Suzuki, Sam Williams, Brian P. Awili, Mustafa Sengupta, Vikram Walsh, James J. Qian, Sascha Lightner, Amy L. Ransom, John T. Melson, Timothy I. Park, David J.
Author_xml	– sequence: 1 givenname: Amy L. surname: Lightner fullname: Lightner, Amy L. – sequence: 2 givenname: Vikram surname: Sengupta fullname: Sengupta, Vikram – sequence: 3 givenname: Sascha surname: Qian fullname: Qian, Sascha – sequence: 4 givenname: John T. surname: Ransom fullname: Ransom, John T. – sequence: 5 givenname: Sam surname: Suzuki fullname: Suzuki, Sam – sequence: 6 givenname: David J. surname: Park fullname: Park, David J. – sequence: 7 givenname: Timothy I. surname: Melson fullname: Melson, Timothy I. – sequence: 8 givenname: Brian P. surname: Williams fullname: Williams, Brian P. – sequence: 9 givenname: James J. surname: Walsh fullname: Walsh, James J. – sequence: 10 givenname: Mustafa surname: Awili fullname: Awili, Mustafa
BookMark	eNqdjz1rwzAQhjWkkI_mF3S5P2BXsovBa5OYZgiFNmQVQj1jGVkKJ7mtp_71KqVTl0Km4w6e995nyWbOO2TsTvBccFHd97nuMMS84EWZ8yrnxcOMLTgXRVZWdTFnyxB6nnZRVwv29ZhoOCgi_wEHDOh0Nw3KwmvEATZobbZFMu_4BrvPSEqny2gVwQmD0RZh79oxGO-g9QSxQzgSqjigi-BbeMFwNqSipwkaZexICA35lPx82m8zUd-ym1bZgOvfuWJlsztunjJNPgTCVp7JDIomKbi8-Mle_vjJi5_klUx-5YrVfyhtooqpVqps7D_sNR-_AVQ6dJg
CitedBy_id	crossref_primary_10_1055_a_2139_1976
Cites_doi	10.1016/S2213-2600(14)70291-7 10.1089/scd.2020.0095 10.1056/NEJMoa2201662 10.1001/jama.2022.23257 10.1038/s41598-021-00726-4 10.1016/S2213-2600(18)30418-1 10.1007/s13770-022-00441-9 10.1016/j.bcp.2021.114800 10.1001/jama.2020.16349 10.1016/S2213-2600(20)30076-X 10.1186/s13045-021-01037-x 10.1001/jama.2021.11330 10.1016/S0140-6736(20)31022-9 10.1080/22221751.2022.2059405 10.1056/NEJMoa2007764 10.1016/j.jcyt.2022.10.003 10.1056/NEJMoa2115869 10.1056/NEJMoa2100433 10.1177/0885066621994476 10.3389/fimmu.2014.00608 10.1089/scd.2020.0080 10.1016/S0140-6736(21)00676-0 10.1038/s41573-023-00672-y 10.14336/AD.2020.0228 10.1038/s41379-020-0536-x 10.1080/17476348.2020.1804365 10.1056/NEJMoa2021436 10.1186/s13287-021-02138-7 10.1186/s13287-021-02143-w
ContentType	Journal Article
DBID	AAYXX CITATION
DOI	10.1016/j.chest.2023.06.024 10.1016/j.chest.2023.06.024.
DatabaseName	CrossRef
DatabaseTitle	CrossRef
DeliveryMethod	fulltext_linktorsrc
Discipline	Medicine
EndPage	1453
ExternalDocumentID	10_1016_j_chest_2023_06_024
GroupedDBID	--- .1- .55 .FO .GJ .XZ 08P 0R~ 18M 1P~ 29B 2WC 354 36B 3O- 457 53G 5GY 5RE 5RS 6J9 6PF 7RV 7X7 88E 8AO 8C1 8F7 8FI 8FJ AAEDT AAEDW AAKAS AAKUH AALRI AAWTL AAXUO AAYOK AAYWO AAYXX ABDBF ABDQB ABJNI ABLJU ABMAC ABOCM ABUWG ACBMB ACGFO ACGFS ACGUR ACUHS ACVFH ADBBV ADCNI ADGHP ADVLN ADZCM AENEX AEUPX AEVXI AFCTW AFETI AFFNX AFJKZ AFKRA AFPUW AFRHN AFTJW AGCQF AGHFR AHMBA AI. AIGII AITUG AJUYK AKBMS AKRWK AKYEP ALIPV ALMA_UNASSIGNED_HOLDINGS AMRAJ APXCP AZQEC B0M BCGUY BENPR BKEYQ BKNYI BPHCQ BVXVI C1A C45 CCPQU CITATION CS3 DU5 EAP EAS EBC EBD EBS EHN EJD EMK ENC EPT ESX EX3 F5P FDB FYUFA GD~ H13 HMCUK HX~ HZ~ IH2 INR J5H K9- L7B LXL LXN M0R M1P M5~ MJL MV1 N4W N9A NAPCQ NEJ O6. O9- OB3 OBH ODZKP OFXIZ OGROG OHH OI- OU. OVD OVIDX P2P PCD PHGZM PHGZT PQQKQ PROAC PSQYO Q~Q RIG ROL SJN SSZ TCP TEORI TR2 TUS TWZ UKHRP VH1 W8F WH7 WOQ WOW X7M XOL YFH YHG YOC YQJ Z5R ZGI ZRQ ZXP ZY1 ~8M
ID	FETCH-crossref_primary_10_1016_j_chest_2023_06_0243
ISSN	0012-3692
IngestDate	Thu Apr 24 23:02:28 EDT 2025 Tue Jul 01 04:19:42 EDT 2025
IsPeerReviewed	true
IsScholarly	true
Issue	6
Language	English
LinkModel	OpenURL
MergedId	FETCHMERGED-crossref_primary_10_1016_j_chest_2023_06_0243
ParticipantIDs	crossref_citationtrail_10_1016_j_chest_2023_06_024 crossref_primary_10_1016_j_chest_2023_06_024
ProviderPackageCode	CITATION AAYXX
PublicationCentury	2000
PublicationDate	2023-12-00
PublicationDateYYYYMMDD	2023-12-01
PublicationDate_xml	– month: 12 year: 2023 text: 2023-12-00
PublicationDecade	2020
PublicationTitle	Chest
PublicationYear	2023
References	Tang (10.1016/j.chest.2023.06.024_bib12) 2021; 12 Yu (10.1016/j.chest.2023.06.024_bib30) 2022; 11 Spinner (10.1016/j.chest.2023.06.024_bib28) 2020; 324 Wilson (10.1016/j.chest.2023.06.024_bib4) 2015; 3 Horby (10.1016/j.chest.2023.06.024_bib15) 2021; 384 Malgie (10.1016/j.chest.2023.06.024_bib18) 2021; 11 Shankar-Hari (10.1016/j.chest.2023.06.024_bib27) 2021; 326 Reis (10.1016/j.chest.2023.06.024_bib26) 2022; 386 De Jong (10.1016/j.chest.2023.06.024_bib9) 2014; 5 Bramante (10.1016/j.chest.2023.06.024_bib21) 2022; 387 Matthay (10.1016/j.chest.2023.06.024_bib7) 2019; 7 Wang (10.1016/j.chest.2023.06.024_bib29) 2020; 395 Leng (10.1016/j.chest.2023.06.024_bib5) 2020; 11 Group (10.1016/j.chest.2023.06.024_bib23) 2021; 397 Sengupta (10.1016/j.chest.2023.06.024_bib14) 2020; 29 Zhou (10.1016/j.chest.2023.06.024_bib8) 2021; 14 Hasan (10.1016/j.chest.2023.06.024_bib3) 2020; 14 Sengupta (10.1016/j.chest.2023.06.024_bib13) 2020; 29 Gordon (10.1016/j.chest.2023.06.024_bib22) 2021; 384 De Clercq (10.1016/j.chest.2023.06.024_bib17) 2021; 193 Xu (10.1016/j.chest.2023.06.024_bib2) 2020; 8 Li (10.1016/j.chest.2023.06.024_bib25) 2023; 22 Krishnan (10.1016/j.chest.2023.06.024_bib11) 2022; 19 El-Solh (10.1016/j.chest.2023.06.024_bib16) 2021; 36 Higgins (10.1016/j.chest.2023.06.024_bib24) 2023; 329 Kirkham (10.1016/j.chest.2023.06.024_bib6) 2023; 25 Kaspi (10.1016/j.chest.2023.06.024_bib10) 2021; 12 Beigel (10.1016/j.chest.2023.06.024_bib20) 2020; 383 Tian (10.1016/j.chest.2023.06.024_bib1) 2020; 33
References_xml	– volume: 3 start-page: 24 issue: 1 year: 2015 ident: 10.1016/j.chest.2023.06.024_bib4 article-title: Mesenchymal stem (stromal) cells for treatment of ARDS: a phase 1 clinical trial publication-title: Lancet Respir Med doi: 10.1016/S2213-2600(14)70291-7 – volume: 29 start-page: 879 issue: 14 year: 2020 ident: 10.1016/j.chest.2023.06.024_bib14 article-title: Response to Lim et al. re: "Exosomes Derived from Bone Marrow Mesenchymal Stem Cells as Treatment for Severe COVID-19." publication-title: Stem Cells Develop doi: 10.1089/scd.2020.0095 – volume: 387 start-page: 599 issue: 7 year: 2022 ident: 10.1016/j.chest.2023.06.024_bib21 article-title: Randomized trial of metformin, ivermectin, and fluvoxamine for Covid-19 publication-title: N Engl J Med doi: 10.1056/NEJMoa2201662 – volume: 329 start-page: 39 issue: 1 year: 2023 ident: 10.1016/j.chest.2023.06.024_bib24 article-title: Long-term (180-day) outcomes in critically ill patients with COVID-19 in the REMAP-CAP randomized clinical trial publication-title: JAMA doi: 10.1001/jama.2022.23257 – volume: 11 issue: 1 year: 2021 ident: 10.1016/j.chest.2023.06.024_bib18 article-title: Decreased mortality and increased side effects in COVID-19 patients treated with IL-6 receptor antagonists: systematic review and meta-analysis publication-title: Sci Rep doi: 10.1038/s41598-021-00726-4 – volume: 7 start-page: 154 issue: 2 year: 2019 ident: 10.1016/j.chest.2023.06.024_bib7 article-title: Treatment with allogeneic mesenchymal stromal cells for moderate to severe acute respiratory distress syndrome (START study): a randomised phase 2a safety trial publication-title: Lancet Respir Med doi: 10.1016/S2213-2600(18)30418-1 – volume: 19 start-page: 659 issue: 4 year: 2022 ident: 10.1016/j.chest.2023.06.024_bib11 article-title: Mesenchymal stem cell-derived extracellular vesicles in the management of COVID19-associated lung injury: a review on publications, clinical trials and patent landscape publication-title: Tissue Eng Regen Med doi: 10.1007/s13770-022-00441-9 – volume: 193 year: 2021 ident: 10.1016/j.chest.2023.06.024_bib17 article-title: Remdesivir: quo vadis? publication-title: Biochemical Pharmacology doi: 10.1016/j.bcp.2021.114800 – volume: 324 start-page: 1048 issue: 11 year: 2020 ident: 10.1016/j.chest.2023.06.024_bib28 article-title: Effect of remdesivir vs standard care on clinical status at 11 days in patients with moderate COVID-19: a randomized clinical trial publication-title: JAMA doi: 10.1001/jama.2020.16349 – volume: 8 start-page: 420 issue: 4 year: 2020 ident: 10.1016/j.chest.2023.06.024_bib2 article-title: Pathological findings of COVID-19 associated with acute respiratory distress syndrome publication-title: Lancet Respir Med doi: 10.1016/S2213-2600(20)30076-X – volume: 14 start-page: 24 issue: 1 year: 2021 ident: 10.1016/j.chest.2023.06.024_bib8 article-title: Challenges and advances in clinical applications of mesenchymal stromal cells publication-title: J Hematol Oncol doi: 10.1186/s13045-021-01037-x – volume: 326 start-page: 499 issue: 6 year: 2021 ident: 10.1016/j.chest.2023.06.024_bib27 article-title: Association between administration of IL-6 antagonists and mortality among patients hospitalized for COVID-19: a meta-analysis publication-title: JAMA doi: 10.1001/jama.2021.11330 – volume: 395 start-page: 1569 issue: 10236 year: 2020 ident: 10.1016/j.chest.2023.06.024_bib29 article-title: Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial publication-title: Lancet doi: 10.1016/S0140-6736(20)31022-9 – volume: 11 start-page: 1154 issue: 1 year: 2022 ident: 10.1016/j.chest.2023.06.024_bib30 article-title: Clinical efficacy and safety of interleukin-6 receptor antagonists (tocilizumab and sarilumab) in patients with COVID-19: a systematic review and meta-analysis publication-title: Emerg Microbes Infect doi: 10.1080/22221751.2022.2059405 – volume: 383 start-page: 1813 issue: 19 year: 2020 ident: 10.1016/j.chest.2023.06.024_bib20 article-title: Remdesivir for the treatment of Covid-19—final report publication-title: N Engl J Med doi: 10.1056/NEJMoa2007764 – volume: 25 start-page: 341 issue: 3 year: 2023 ident: 10.1016/j.chest.2023.06.024_bib6 article-title: Systematic review and meta-analysis of randomized controlled trials of mesenchymal stromal cells to treat coronavirus disease 2019: is it too late? publication-title: Cytotherapy doi: 10.1016/j.jcyt.2022.10.003 – volume: 386 start-page: 1721 issue: 18 year: 2022 ident: 10.1016/j.chest.2023.06.024_bib26 article-title: Effect of early treatment with ivermectin among patients with Covid-19 publication-title: N Engl J Med doi: 10.1056/NEJMoa2115869 – volume: 384 start-page: 1491 issue: 16 year: 2021 ident: 10.1016/j.chest.2023.06.024_bib22 article-title: Interleukin-6 receptor antagonists in critically ill patients with Covid-19 publication-title: N Engl J Med doi: 10.1056/NEJMoa2100433 – volume: 36 start-page: 664 issue: 6 year: 2021 ident: 10.1016/j.chest.2023.06.024_bib16 article-title: Clinical course and outcome of COVID-19 acute respiratory distress syndrome: data from a national repository publication-title: J Intensive Care Med doi: 10.1177/0885066621994476 – volume: 5 start-page: 608 year: 2014 ident: 10.1016/j.chest.2023.06.024_bib9 article-title: Extracellular vesicles: potential roles in regenerative medicine publication-title: Front Immunol doi: 10.3389/fimmu.2014.00608 – volume: 29 start-page: 747 issue: 12 year: 2020 ident: 10.1016/j.chest.2023.06.024_bib13 article-title: Exosomes derived from bone marrow mesenchymal stem cells as treatment for severe COVID-19 publication-title: Stem Cells Develop doi: 10.1089/scd.2020.0080 – volume: 397 start-page: 1637 issue: 10285 year: 2021 ident: 10.1016/j.chest.2023.06.024_bib23 article-title: Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial publication-title: Lancet doi: 10.1016/S0140-6736(21)00676-0 – volume: 22 start-page: 449 issue: 6 year: 2023 ident: 10.1016/j.chest.2023.06.024_bib25 article-title: Therapeutic strategies for COVID-19: progress and lessons learned publication-title: Nat Rev Drug Discov doi: 10.1038/s41573-023-00672-y – volume: 11 start-page: 216 issue: 2 year: 2020 ident: 10.1016/j.chest.2023.06.024_bib5 article-title: Transplantation of ACE2(-) mesenchymal stem cells improves the outcome of patients with COVID-19 pneumonia publication-title: Aging Dis doi: 10.14336/AD.2020.0228 – volume: 33 start-page: 1007 issue: 6 year: 2020 ident: 10.1016/j.chest.2023.06.024_bib1 article-title: Pathological study of the 2019 novel coronavirus disease (COVID-19) through postmortem core biopsies publication-title: Modern Pathol doi: 10.1038/s41379-020-0536-x – volume: 14 start-page: 1149 issue: 11 year: 2020 ident: 10.1016/j.chest.2023.06.024_bib3 article-title: Mortality in COVID-19 patients with acute respiratory distress syndrome and corticosteroids use: a systematic review and meta-analysis publication-title: Expert Rev Respir Med doi: 10.1080/17476348.2020.1804365 – volume: 384 start-page: 693 issue: 8 year: 2021 ident: 10.1016/j.chest.2023.06.024_bib15 article-title: Dexamethasone in hospitalized patients with Covid-19 publication-title: N Engl J Med doi: 10.1056/NEJMoa2021436 – volume: 12 start-page: 71 issue: 1 year: 2021 ident: 10.1016/j.chest.2023.06.024_bib12 article-title: Advances in mesenchymal stem cell exosomes: a review publication-title: Stem Cell Res Ther doi: 10.1186/s13287-021-02138-7 – volume: 12 start-page: 72 issue: 1 year: 2021 ident: 10.1016/j.chest.2023.06.024_bib10 article-title: MSC-NTF (NurOwn®) exosomes: a novel therapeutic modality in the mouse LPS-induced ARDS model publication-title: Stem Cell Res Ther doi: 10.1186/s13287-021-02143-w
SSID	ssj0001196
Score	4.8807793
SourceID	crossref
SourceType	Index Database Enrichment Source
StartPage	1444
Title	Bone Marrow Mesenchymal Stem Cell-Derived Extracellular Vesicle Infusion for the Treatment of Respiratory Failure From COVID-19 Bone Marrow Mesenchymal Stem Cell-Derived Extracellular Vesicle Infusion for the Treatment of Respiratory Failure From COVID-19: A Randomized, Placebo-Controlled Dosing Clinical Trial
Volume	164
hasFullText	1
inHoldings	1
isFullTextHit
isPrint
link	http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT-MwELZKkVZ7QTwWLU_NgVs3EUndtBzLS7zKSqgUbpFJHSg0LSopAi78OX4YM4ntmocQ5RJVaTR14q8z48k3nxlbw6SjXa2ImhNXZeDwtl9xhIh9J4j9oCbXeeRF1ODcOA72TvnBeeW8UHixWEvD9MKNnj7tK_nJrOI5nFfqkh1jZo1RPIGfcX7xiDOMx2_N8Wa_R1sHkYxiqUFtRNHVY0LyHqlMSluy23W2cRj3mFPuPKQDQUX6jHXakndkCp1DPLyzuYZNQzvPNEpGb-F3RYf465jn9tHy_9b-tqN8kFY5uNLvqYjdQyt-1UlTTx5LR64p5Mje5fA2z1hbnZuBSEzltaNKsQLX2yZWnGAk7SeaM1xqunaVwi9bjA_leUkcMdh463lzAXMFMduP4jKPWzHZ47mi8Ad_n5cert1sczGXfjhTY83bsr9_tTuKhpoB8C5IGuqiZsVdh5mVkKyExA30-QSb9KuYwRXZZP3w5OzQZASel-0TZ56BVr_KeIYfBqMbPD__1rUSKCsTak6zKbWEgXqOxxlWkL1Z9quhSBpz7JlgCTkswYIlECzBhiW8gSUoWIKGJSAsAWEJBpbQj8GCJShYAsESNCz_sPLuTnNrz9E3EN7mkirhF0-1PM-KPRz3Xwbci8tBDYMU-hQeS0-styMpuKhKzLAwMC0w31iOlMQ97bTS_cr-Avs3znAWx7t8if0e_R2WWTEdDOUKprHpxapCySu6-Z3I
linkProvider	Library Specific Holdings
openUrl	ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Bone+Marrow+Mesenchymal+Stem+Cell-Derived+Extracellular+Vesicle+Infusion+for+the+Treatment+of+Respiratory+Failure+From+COVID-19&rft.jtitle=Chest&rft.au=Lightner%2C+Amy+L.&rft.au=Sengupta%2C+Vikram&rft.au=Qian%2C+Sascha&rft.au=Ransom%2C+John+T.&rft.date=2023-12-01&rft.issn=0012-3692&rft.volume=164&rft.issue=6&rft.spage=1444&rft.epage=1453&rft_id=info:doi/10.1016%2Fj.chest.2023.06.024&rft_id=info:doi/10.1016%2Fj.chest.2023.06.024.&rft.externalDBID=n%2Fa&rft.externalDocID=10_1016_j_chest_2023_06_024
thumbnail_l	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0012-3692&client=summon
thumbnail_m	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0012-3692&client=summon
thumbnail_s	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0012-3692&client=summon